Japan’s 2014 Drug Price Reforms Extend Price Premium Program
This article was originally published in PharmAsia News
Executive Summary
The Japanese government has decided to revise its drug pricing policies starting in April 2014. Changes include extending a price premium program for two more years, bundling the pricing of similar generic drugs, and reduced pricing on long-listed drugs.